10月18日上午,艾美疫苗(06660)股价出现大涨行情,盘中一度上涨5.7%,报7.25港元。
分析人士认为,导致艾美疫苗股价走高的主要原因是南向资金连续5日净买入该股,买盘较为集中。数据显示,截至10月17日收盘,港股通共持有艾美疫苗4404.54万股,占其流通股8.94%,持股比例可观。
南向资金持续加仓艾美疫苗或反映了机构投资者对该公司未来业绩的乐观预期。作为国内领先的疫苗研发企业,艾美疫苗目前在研数款重磅疫苗产品,包括mRNA新冠疫苗和广谱新冠疫苗等。如果这些产品能够顺利上市,将有望推动公司收入和利润水平进一步提升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.